Trial Profile
Randomized PI switch
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; HIV protease inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 07 Mar 2008 Status changed from in progress to completed, according to ClinicalTrials.gov
- 12 Feb 2007 New trial record.